Table 3.
Detailed parameters of ROC curve assessment for appraisal of the diagnostic power of genes in distinguishing COVID-19 patients from healthy controls and in distinguishing ICU-hospitalized patients from the non-ICU patients (Se: sensitivity, Sp: specifciicty)
SNHG6 | SNHG16 | VDR | Linc00511 | Linc00346 | CYP27B | All | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of Samples | AUC | Se | Sp | AUC | Se | Sp | AUC | Se | Sp | AUC | Se | Sp | AUC | Se | Sp | AUC | Se | Sp | AUC | Se | Sp | |
Total patients/ controls | ||||||||||||||||||||||
Total | 91/91 | 0.66 | 0.60 | 0.66 | 0.67 | 0.70 | 0.59 | 0.58 | 0.52 | 0.66 | 0.52 | 0.58 | 0.50 | 0.52 | 0.41 | 0.65 | 0.52 | 0.51 | 0.59 | 0.76 | 0.62 | 0.81 |
ICU/Non_ICU | ||||||||||||||||||||||
Total | 37/54 | 0.54 | 0.46 | 0.67 | 0.54 | 0.74 | 0.40 | 0.62 | 0.48 | 0.72 | 0.50 | 0.97 | 0.08 | 0.54 | 0.23 | 0.87 | 0.57 | 0.81 | 0.33 | 0.53 | 0.25 | 0.84 |